Beryl Drugs Limited announced earnings results for the second quarter ended September 30, 2019. For the second quarter, the company announced total revenue was INR 33.409 million compared to INR 35.959 million a year ago. Operating income was INR 2.309 million compared to INR 2.549 million a year ago. Net income was INR 1.735 million compared to INR 1.408 million a year ago. Basic earnings per share was INR 0.34 compared to INR 0.28 a year ago. For the half year, total revenue was INR 75.739 million compared to INR 77.832 million a year ago. Operating income was INR 6.160 million compared to INR 5.073 million a year ago. Net income was INR 5.161 million compared to INR 3.432 million a year ago. Basic earnings per share was INR 1.02 compared to INR 0.68 a year ago.